<DOC>
	<DOCNO>NCT01211626</DOCNO>
	<brief_summary>The overall study design include two part , Part A Part B . Part A evaluated ANA773 follow oral administration healthy volunteer . A total 40 evaluable healthy volunteer enrol Part A study . Part B evaluate ANA773 follow oral administration patient chronic HCV infection . A total 34 evaluable patient enrol Part B study 2 study center .</brief_summary>
	<brief_title>Study ANA773 Healthy Volunteers Patients With Hepatitis C Virus ( HCV ) Assess Safety , Tolerability , Pharmacokinetics ( PK ) Pharmacodynamics ( PD )</brief_title>
	<detailed_description>Study Design : Part A evaluate ANA773 follow oral administration healthy volunteer . A total 40 evaluable healthy volunteer enrol Part A study . Part B evaluate ANA773 follow oral administration patient chronic HCV infection . A total 34 evaluable patient enrol Part B study 2 study center .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<criteria>Part A Inclusion : Male female , age 18 65 year No clinically significant abnormality No serious severe chronic condition Nonsmokers Part A Exclusion : Female subject pregnant breastfeed History significant medical condition could interfere study medication associate study assessment History current drug alcohol abuse Part B Male female , age 18 65 year Diagnosed chronic liver disease consistent chronic hepatitis C infection least 6 month Screening HCV RNA ≥ 375,000 copies/mL ≥ 75,000 IU/mL Naïve relapse prior IFNalpha base therapy Part B Female subject pregnant breastfeed Received antiviral therapy immunomodulatory therapy within 90 day prior administration first dose study medication Use investigational drug participation investigational study license drug within 30 day History significant medical condition could interfere study medication associate study assessment History current drug alcohol abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>